We are live on ! Find out more
SO

STRS Ohio Portfolio holdings

AUM $25.2B
1-Year Est. Return 30.31%
This Fund
S&P 500
This Quarter Est. Return
-2.05%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$22.5B
AUM Growth
-$1.23B
Cap. Flow
-$523M
Cap. Flow %
-2.33%
Top 10 Hldgs %
24.5%
Holding
2,086
New
157
Increased
581
Reduced
721
Closed
155

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$50M
2
NVDA icon
NVIDIA
NVDA
+$47.5M
3
VTR icon
Ventas
VTR
+$44.8M
4
MTB icon
M&T Bank
MTB
+$28.3M
5
AON icon
Aon
AON
+$24.9M

Top Sells

Rank Stock Value
1
EQR icon
Equity Residential
EQR
+$37.7M
2
MA icon
Mastercard
MA
+$30.5M
3
PLNT icon
Planet Fitness
PLNT
+$28.6M
4
AAPL icon
Apple
AAPL
+$28.3M
5
TMO icon
Thermo Fisher Scientific
TMO
+$28M

Sector Composition

Rank Sector Weight
1 Technology 25.57%
2 Healthcare 12.96%
3 Financials 12.52%
4 Consumer Discretionary 10.14%
5 Industrials 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVDX
1576
DELISTED
AvidXchange
AVDX
$189K ﹤0.01%
20,000
-56,900
-74% -$596K
KFY icon
1577
Korn Ferry
KFY
$3.98B
$189K ﹤0.01%
4,000
+3,000
+300% +$152K
MODV
1578
DELISTED
ModivCare
MODV
$189K ﹤0.01%
6,000
+5,600
+1,400% +$219K
TWI icon
1579
Titan International
TWI
$516M
$189K ﹤0.01%
14,100
-19,600
-58% -$239K
RPT
1580
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$189K ﹤0.01%
17,900
GCO icon
1581
Genesco
GCO
$396M
$188K ﹤0.01%
6,100
OFLX icon
1582
Omega Flex
OFLX
$298M
$188K ﹤0.01%
2,400
+800
+50% +$69.1K
ADMA icon
1583
ADMA Biologics
ADMA
$1.92B
$184K ﹤0.01%
51,400
+20,900
+69% +$80.4K
ARLO icon
1584
Arlo Technologies
ARLO
$1.4B
$184K ﹤0.01%
17,900
+12,000
+203% +$127K
NMRK icon
1585
Newmark Group
NMRK
$2.73B
$184K ﹤0.01%
28,700
BSRR icon
1586
Sierra Bancorp
BSRR
$548M
$183K ﹤0.01%
9,700
-14,700
-60% -$289K
PGRE
1587
DELISTED
Paramount Group
PGRE
$183K ﹤0.01%
39,700
-46,574
-54% -$230K
BBIO icon
1588
BridgeBio Pharma
BBIO
$16.5B
$181K ﹤0.01%
+6,900
New +$196K
NUVL
1589
DELISTED
Nuvalent
NUVL
$179K ﹤0.01%
3,900
-6,800
-64% -$302K
FLNA
1590
Filana Therapeutics
FLNA
$43M
$179K ﹤0.01%
10,800
-1,900
-15% -$37.7K
UTI icon
1591
Universal Technical Institute
UTI
$2.08B
$178K ﹤0.01%
21,300
COMP icon
1592
Compass
COMP
$8.27B
$176K ﹤0.01%
60,900
UGP icon
1593
Ultrapar
UGP
$6.87B
$176K ﹤0.01%
48,000
BPMC
1594
DELISTED
Blueprint Medicines
BPMC
$175K ﹤0.01%
3,500
-1,400
-29% -$74.8K
OMCL icon
1595
Omnicell
OMCL
$1.86B
$175K ﹤0.01%
3,900
+1,300
+50% +$78.8K
MTUS icon
1596
Metallus
MTUS
$873M
$175K ﹤0.01%
8,100
-9,500
-54% -$207K
IBP icon
1597
Installed Building Products
IBP
$6.13B
$174K ﹤0.01%
1,400
+400
+40% +$56.5K
RVMD icon
1598
Revolution Medicines
RVMD
$40.2B
$174K ﹤0.01%
6,300
+4,600
+271% +$136K
ENTA icon
1599
Enanta Pharmaceuticals
ENTA
$372M
$173K ﹤0.01%
15,500
BL icon
1600
BlackLine
BL
$1.69B
$171K ﹤0.01%
3,100
+500
+19% +$27.4K

Similar funds

STRS Ohio's Q3 2023 Portfolio in Review

As of Q3 2023, STRS Ohio held 2,086 positions worth $22.5B, down 5.2% from $23.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

STRS Ohio's Q3 2023 filing shows 157 new, 581 increased, 721 reduced and 155 closed positions. Its largest new stake was Kenvue: 2,159,326 shares worth $43.4M. The largest sale was Equity Residential, an estimated $37.7M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

  • STRS Ohio's largest Q3 2023 buy was Kenvue: 2,159,326 shares worth $43.4M.
  • STRS Ohio added most to NVIDIA in Q3 2023, an estimated $47.5M increase.
  • STRS Ohio's biggest Q3 2023 reduction was Equity Residential, cutting an estimated $37.7M.
  • STRS Ohio fully exited Planet Fitness in Q3 2023, selling an estimated $28.6M.
  • STRS Ohio's ten largest holdings make up 24% of its $22.5B portfolio in Q3 2023.
  • STRS Ohio opened 157 new positions and closed 155 in Q3 2023.
  • STRS Ohio's portfolio value fell 5.2% quarter-over-quarter to $22.5B.

Based on STRS Ohio's 13F filing for Q3 2023, filed 26 Oct 2023.